The ADD1 Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population featuring targeted disruption of the ADD1 gene in the HeLa human cervical adenocarcinoma epithelial cell line. This loss-of-function model enables investigation of alpha-adducin??s roles in cytoskeletal organization, ion transport, and cell adhesion without the isolation of a single clonal derivative. The polyclonal population preserves genetic heterogeneity while eliminating functional ADD1 expression, providing a robust system for studying the collective cellular responses to alpha-adducin ablation. Researchers can employ these cells to dissect the molecular mechanisms underlying cytoskeletal dynamics, sodium homeostasis, and cancer cell behavior.
HeLa cells are an immortalized epithelial cell line derived from a cervical adenocarcinoma and are widely utilized as a model for human cancer biology, signal transduction, and drug discovery. Their well-characterized proteome, ease of culture, and amenability to genetic manipulation make them an ideal host for CRISPR/Cas9-mediated gene disruption. In these ADD1 knockout polyclonal cells, the HeLa background provides a relevant context for examining how loss of alpha-adducin impacts oncogenic processes, including altered cell adhesion, migration, and ion transport regulation.
ADD1 encodes alpha-adducin, a membrane-associated cytoskeletal protein that binds to spectrin?Cactin networks, thereby stabilizing the cortical cytoskeleton and modulating the activity of transmembrane ion transporters such as Na+/K+ ATPase. Alpha-adducin is phosphorylated by upstream regulators including protein kinase C (PKC) and Rho-associated kinase (ROCK), and it is regulated by calcium/calmodulin binding. Through interactions with beta-adducin, spectrin, actin, calmodulin, and TRPC6, alpha-adducin orchestrates cytoskeletal remodeling and ion transport. Knockout of ADD1 disrupts these complexes, leading to altered spectrin?Cactin dynamics, reduced membrane stability, and dysregulated Na+/K+ ATPase function, which in turn affects cellular adhesion mediated by E-cadherin and downstream RhoA signaling.
In the HeLa cellular context, ablation of alpha-adducin profoundly impacts pathways governing cell adhesion, migration, and sodium transport. Given HeLa cells?? origin from cervical adenocarcinoma, this knockout model is particularly valuable for dissecting how cytoskeletal changes contribute to cancer cell invasiveness and metastatic potential. The loss of ADD1 may perturb adherens junction integrity through its effects on E-cadherin and actin, while also compromising ion homeostasis, thereby mimicking aspects of salt-sensitive hypertension and renal tubular acidosis at the cellular level. Consequently, this model serves as a versatile platform for mechanistic studies spanning cancer biology, cardiovascular research, and epithelial transport physiology.
These polyclonal knockout cells are suitable for a wide range of experimental applications including hypertension modeling, cytoskeletal dynamics analysis, ion transport assessment, cell adhesion and migration assays, and drug screening for ion transport modulators. Typical assays include Western blotting for ADD1 and spectrin, immunofluorescence visualization of the actin cytoskeleton, Na+/K+ ATPase activity measurements, cell adhesion and migration/invasion assays, and RhoA activity assays. By leveraging this knockout population, researchers can interrogate ADD1-dependent signaling networks and identify novel therapeutic targets. For further information, please contact Ascent Research.
